Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Paul T. Kirschmeier

机构：Merck & Co., Inc., Rahway, NJ, USA (United States), Dana-Farber Cancer Institute, Center for Orthopaedics, Center for Cancer Research

发表论文 332 篇 · 总被引 13242 次 · h-index 53

代表论文

  • Data from The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity (2023)
  • Supplemental Figures 1-8 from The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity (2023)
  • Supplementary Figure Legends, Tables and Methods from The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity (2023)
  • Supplementary Figure Legends, Tables and Methods from The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity (2023)
  • Supplemental Figures 1-8 from The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity (2023)
  • Data from The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity (2023)